other material
confidence high
sentiment neutral
materiality 0.65
TherapeuticsMD raises $7M via Series A Preferred from Rubric Capital, extends debt maturity to Oct 31
TherapeuticsMD, Inc.
- Issued 7,000 Series A Preferred shares to Rubric Capital Management for $7M gross proceeds; proceeds for working capital.
- Financing agreement maturity extended to Oct 31, 2022; further extension to Nov 30 possible with additional $7M equity raise.
- Issued warrants to Sixth Street lenders for 125,000 common shares at $0.01 exercise price, expiring Sep 30, 2032.
- Company continues strategic alternatives process to strengthen long-term financial position.
- Securities issued in private placement under Section 4(a)(2) and Regulation D; no registration rights granted.